System Transmission

Top Signal

100#1 JOB

Activity

2171Ripe

+927 today

System

Livenow

Terminal Asset View

stockNASDAQ

NBIX

$129.78+1.57%

Neurocrine Biosciences Inc

Ripe

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

82Ripe

Live Analysis Active

Company Mission

It creates medicines for brain and hormone-related diseases, such as movement disorders and rare conditions. Doctors prescribe these drugs to patients who need specialized treatments. The company makes money by selling these medications and collaborating with other drug makers on research and development projects.

NBI

Industry Context

This company operates in the biotechnology sector, focusing on developing drugs for neurological and endocrine conditions. It competes with larger pharmaceutical firms by targeting niche markets with high unmet medical needs. The industry is growing due to increasing awareness and funding for mental health and rare disorders.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

87Matrix

Market Momentum

45.5— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.9x— Normal Volume

Today's Change

1.57%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Price energy is building quickly for a potential move. Bullish alignment confirmed.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing NBIX across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 11:22 PM UTC

As-of As of 2026-03-15T23:07:41.176Z UTC (~15m delay).

Develops prescription drugs for neurological and endocrine disorders, generating revenue from sales to patients and healthcare providers.

Price consolidating near $150, suggesting stability as it tests key support. Watch for a breakout above to confirm bullish momentum.

Volume increased 2x at $148, indicating buyer interest because it aligns with recent positive news. Monitor if volume stays elevated above average.

Industry trend toward rare disease therapies is driving strength, with price holding above $145, signaling resilience. Watch for sector expansion announcements.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...